Creating a Hybrid Care Plan for Heart Failure Patients

Soundos Moualla, MD, FACC, FSCAI
Interventional Cardiology
Dignity Health, Yavapai Regional Medical Center

Congestive heart failure (CHF) results in poor patient outcomes and increases the cost of care particularly with recurrent CHF hospitalizations. Using the CardioCare platform, we have started prospectively cross-matching the CardioCare alerts with hospital heart failure admissions for both aortic stenosis (AS) and mitral regurgitation (MR) patients. This has allowed us to provide better patient care by creating a daily alert system, that improved communication and coordination of care with the heart failure team at Dignity Health, Yavapai Regional Medical Center. This process led to more expeditious care of acutely ill patients, subsequently reducing re-admission rates of patients with congestive heart failure.

In the last year, 224 patients diagnosed with severe mitral regurgitation were also admitted to the hospital with heart failure. With this data, our team created a hybrid care plan among multiple clinical disciplines to increase disease awareness, implement therapeutic interventions based on guidelines, and improve the outcomes of this patient population.

Below is an example of sample data from the CardioCare platform, with reconciled plan of care:

 *Illustrative Data

In addition to the approach above, we plan to further collaborate with the heart failure team to look at patients with retrospective CHF admissions; specifically recurrent CHF admissions, and cross-match with aortic stenosis and mitral regurgitation patients from CardioCare.  We anticipate that we will identify patients with untreated valve pathologies (AS and/or MR) with recurrent CHF exacerbations, who previously have not been under the care of the structural heart or heart failure teams. The aim is to ensure these patients are managed appropriately with guideline directed medical therapy, appropriate valvular therapies, and followed appropriately. It is critical for community structural heart programs to have a multifaceted approach to cardiovascular patient care, striving to improve the standards for physicians, allied health organizations, and most importantly patients.

Related Articles

Press

egnite, Inc. and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference

egnite, Inc., a leading digital health company specializing in cardiovascular care, today announced the addition of two distinguished physicians, Vinod H. Thourani, MD and Nicholas Amoroso, MD to its Medical Advisory Board. Their wealth of expertise in cardiovascular care and dedication to innovation will significantly contribute to egnite’s mission to improve cardiovascular patient care nationwide.

Real-World Evidence

Mortality Burden for Patients with Untreated Aortic Regurgitation

“This research underscores the poor outcomes for patients with moderate AR who exhibit cardiac damage, stressing the need to monitor for distinct characteristics in this population. These insights may also prompt a reassessment of our management strategies and suggest a shift in our approach to intensified follow-up for both moderate

Press

egnite, Inc. Announces the Appointment of Vinod Thourani and Nicholas Amoroso to Its Medical Advisory Board

egnite, Inc., a leading digital health company specializing in cardiovascular care, today announced the addition of two distinguished physicians, Vinod H. Thourani, MD and Nicholas Amoroso, MD to its Medical Advisory Board. Their wealth of expertise in cardiovascular care and dedication to innovation will significantly contribute to egnite’s mission to improve cardiovascular patient care nationwide.